BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

628 related articles for article (PubMed ID: 16968795)

  • 1. High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium.
    Daly AF; Rixhon M; Adam C; Dempegioti A; Tichomirowa MA; Beckers A
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4769-75. PubMed ID: 16968795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and characteristics of sellar masses in the city of Al Ain, United Arab Emirates: 2010 to 2016.
    Aldahmani KM; Sreedharan J; Ismail MM; Philip J; Nair SC; Alfelasi M; Aziz W; Imran SA; Alkaabi J
    Ann Saudi Med; 2020; 40(2):105-112. PubMed ID: 32241168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The incidence rate of pituitary adenomas in western Sweden for the period 2001-2011.
    Tjörnstrand A; Gunnarsson K; Evert M; Holmberg E; Ragnarsson O; Rosén T; Filipsson Nyström H
    Eur J Endocrinol; 2014 Oct; 171(4):519-26. PubMed ID: 25084775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coping strategies in patients after treatment for functioning or nonfunctioning pituitary adenomas.
    Tiemensma J; Kaptein AA; Pereira AM; Smit JW; Romijn JA; Biermasz NR
    J Clin Endocrinol Metab; 2011 Apr; 96(4):964-71. PubMed ID: 21209028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epidemiology of pituitary adenomas in Iceland, 1955-2012: a nationwide population-based study.
    Agustsson TT; Baldvinsdottir T; Jonasson JG; Olafsdottir E; Steinthorsdottir V; Sigurdsson G; Thorsson AV; Carroll PV; Korbonits M; Benediktsson R
    Eur J Endocrinol; 2015 Nov; 173(5):655-64. PubMed ID: 26423473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characterization of familial isolated pituitary adenomas.
    Daly AF; Jaffrain-Rea ML; Ciccarelli A; Valdes-Socin H; Rohmer V; Tamburrano G; Borson-Chazot C; Estour B; Ciccarelli E; Brue T; Ferolla P; Emy P; Colao A; De Menis E; Lecomte P; Penfornis F; Delemer B; Bertherat J; Wémeau JL; De Herder W; Archambeaud F; Stevenaert A; Calender A; Murat A; Cavagnini F; Beckers A
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3316-23. PubMed ID: 16787992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Epidemiology of Pituitary Adenomas.
    Daly AF; Beckers A
    Endocrinol Metab Clin North Am; 2020 Sep; 49(3):347-355. PubMed ID: 32741475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review: Pituitary adenomas in children and adolescents.
    Katavetin P; Cheunsuchon P; Swearingen B; Hedley-Whyte ET; Misra M; Levitsky LL
    J Pediatr Endocrinol Metab; 2010 May; 23(5):427-31. PubMed ID: 20662340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic transsphenoidal treatment of hormonally active pituitary adenomas.
    Rudnik A; Kos-Kudła B; Larysz D; Zawadzki T; Bazowski P
    Neuro Endocrinol Lett; 2007 Aug; 28(4):438-44. PubMed ID: 17693972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study.
    Vergès B; Boureille F; Goudet P; Murat A; Beckers A; Sassolas G; Cougard P; Chambe B; Montvernay C; Calender A
    J Clin Endocrinol Metab; 2002 Feb; 87(2):457-65. PubMed ID: 11836268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germline AIP mutations in apparently sporadic pituitary adenomas: prevalence in a prospective single-center cohort of 443 patients.
    Cazabat L; Bouligand J; Salenave S; Bernier M; Gaillard S; Parker F; Young J; Guiochon-Mantel A; Chanson P
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E663-70. PubMed ID: 22319033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric pituitary adenoma: a series of 42 patients.
    Pandey P; Ojha BK; Mahapatra AK
    J Clin Neurosci; 2005 Feb; 12(2):124-7. PubMed ID: 15749410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and endocrine aspects of pituitary tumors.
    Zargar AH; Laway BA; Masoodi SR; Salahuddin M; Ganie MA; Bhat MH; Wani AI; Bashir MI
    Saudi Med J; 2004 Oct; 25(10):1428-32. PubMed ID: 15494816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and prevalence of clinically relevant pituitary adenomas: retrospective cohort study in a Health Management Organization in Buenos Aires, Argentina.
    Day PF; Loto MG; Glerean M; Picasso MF; Lovazzano S; Giunta DH
    Arch Endocrinol Metab; 2016; 60(6):554-561. PubMed ID: 27982201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of familial pituitary adenoma syndromes among patients with functioning pituitary adenomas in a reference outpatient clinic.
    Marques NV; Kasuki L; Coelho MC; Lima CHA; Wildemberg LE; Gadelha MR
    J Endocrinol Invest; 2017 Dec; 40(12):1381-1387. PubMed ID: 28689311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pituitary adenomas in patients with multiple endocrine neoplasia type 1: a single-center experience in China.
    Wu Y; Gao L; Guo X; Wang Z; Lian W; Deng K; Lu L; Xing B; Zhu H
    Pituitary; 2019 Apr; 22(2):113-123. PubMed ID: 30637623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macroprolactinomas and Nonfunctioning Pituitary Adenomas and Pregnancy Outcomes.
    Lambert K; Rees K; Seed PT; Dhanjal MK; Knight M; McCance DR; Williamson C
    Obstet Gynecol; 2017 Jan; 129(1):185-194. PubMed ID: 27926659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National incidence and prevalence of TSH-secreting pituitary adenomas in Sweden.
    Ónnestam L; Berinder K; Burman P; Dahlqvist P; Engström BE; Wahlberg J; Nyström HF
    J Clin Endocrinol Metab; 2013 Feb; 98(2):626-35. PubMed ID: 23295463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study.
    Daly AF; Tichomirowa MA; Petrossians P; Heliövaara E; Jaffrain-Rea ML; Barlier A; Naves LA; Ebeling T; Karhu A; Raappana A; Cazabat L; De Menis E; Montañana CF; Raverot G; Weil RJ; Sane T; Maiter D; Neggers S; Yaneva M; Tabarin A; Verrua E; Eloranta E; Murat A; Vierimaa O; Salmela PI; Emy P; Toledo RA; Sabaté MI; Villa C; Popelier M; Salvatori R; Jennings J; Longás AF; Labarta Aizpún JI; Georgitsi M; Paschke R; Ronchi C; Valimaki M; Saloranta C; De Herder W; Cozzi R; Guitelman M; Magri F; Lagonigro MS; Halaby G; Corman V; Hagelstein MT; Vanbellinghen JF; Barra GB; Gimenez-Roqueplo AP; Cameron FJ; Borson-Chazot F; Holdaway I; Toledo SP; Stalla GK; Spada A; Zacharieva S; Bertherat J; Brue T; Bours V; Chanson P; Aaltonen LA; Beckers A
    J Clin Endocrinol Metab; 2010 Nov; 95(11):E373-83. PubMed ID: 20685857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality in patients treated for Cushing's disease is increased, compared with patients treated for nonfunctioning pituitary macroadenoma.
    Dekkers OM; Biermasz NR; Pereira AM; Roelfsema F; van Aken MO; Voormolen JH; Romijn JA
    J Clin Endocrinol Metab; 2007 Mar; 92(3):976-81. PubMed ID: 17200171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.